Omesdafexor

Modify Date: 2024-09-07 18:16:16

Use of Omesdafexor

Omesdafexor is a FXR agonist. Omesdafexor can be used in the research of liver disease or a metabolic inflammation-mediated disease[1][2].

Name	Omesdafexor

Description	Omesdafexor is a FXR agonist. Omesdafexor can be used in the research of liver disease or a metabolic inflammation-mediated disease[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Metabolic Enzyme/Protease >> FXR Research Areas >> Inflammation/Immunology Research Areas >> Metabolic Disease
References	[1]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl127.pdf?sfvrsn=8544ca1e_3&download=true [2]. Song, Kenneth, et al. Farnesoid X receptor agonists for the treatment of a liver disease or a metabolic inflammation-mediated disease or disorder. Patent WO2020061114.

Description

Omesdafexor is a FXR agonist. Omesdafexor can be used in the research of liver disease or a metabolic inflammation-mediated disease[1][2].

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Metabolic Enzyme/Protease >> FXR

Research Areas >> Inflammation/Immunology

Research Areas >> Metabolic Disease

References